Farm Aid Group
Pharmaceutical manufacturer · Islamabad · Pakistan
Pakistan pharmaceutical manufacturer operating human-health, livestock and poultry medicine divisions, with manufacturing at Hattar Industrial Estate.
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Farm Aid Group / FAG Pharmaceuticals
- Company type
- Pharmaceutical manufacturer
- Address
- Axon Heights, B-Block, Zaraj, Opposite World Trade Center, Giga Mall, Islamabad, Pakistan
- Website
- fagpharmaceuticals.com ↗
- Phone
- +92 51 4847700-01; +92 51 5427274
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Aagic | Loratadine | 10 mg | Tablet | 1 × 10's | 033567 | PKR 123.72 | PKR 12.37/tablet | 14% below median |
| Api farm | Aprepitant | 40 mg | Capsule | 2's | 087478 | PKR 1,791.19 | PKR 895.60/capsule | Near median |
| Api farm | Aprepitant | 80 mg | Capsule | 2's | 087479 | PKR 2,991.47 | PKR 1,495.74/capsule | Near median |
| Aprifarm | Aprepitant | 125 mg | Capsule | 2's | 087480 | PKR 4,671.86 | PKR 2,335.93/capsule | Near median |
| Arlum | Artemether + Lumefantrine | 20 mg + 120 mg | Tablet | 2 x 8's | 051042 | PKR 590.91 | PKR 36.93/tablet | 7% below median |
| Atoxilate Diphenoxylate HCL | Atropine | 2.5 mg | Tablet | 50 × 10's | 033564 | PKR 378.54 | PKR 0.76/tablet | 14% below median |
| Calfa | Clarithromycin | 250 mg | Tablet | 1 × 10's | 051038 | PKR 443.18 | PKR 44.32/tablet | 7% below median |
| Calfa | Clarithromycin | 500 mg | Tablet | 1 × 10's | 051039 | PKR 821.73 | PKR 82.17/tablet | Near median |
| Citradex | Acitretin | 10 mg | Capsule | 3 x 10's | 098987 | PKR 1,071.01 | PKR 35.70/capsule | 10% below median |
| Citradex | Acitretin | 10 mg | Capsule | 1 x 10's | 098987 | PKR 387.78 | PKR 38.78/capsule | Near median |
| Citradex | Acitretin | 10 mg | Capsule | 2 x 10's | 098987 | PKR 738.63 | PKR 36.93/capsule | 7% below median |
| Conafarm | Fluconazole | 50 mg | Capsule | 1 x 7's | 087476 | PKR 830.96 | PKR 118.71/capsule | Near median |
| Conafarm | Fluconazole | 150 mg | Capsule | 1's | 088412 | PKR 254.83 | PKR 254.83/capsule | Near median |
| Eso-Aid | Esomeprazole | 20 mg | Capsule | 2 x 7's | 087474 | PKR 219.74 | PKR 15.70/capsule | 21% below median |
| Eso-Aid | Esomeprazole | 40 mg | Capsule | 2 x 7's | 087475 | PKR 365.63 | PKR 26.12/capsule | 21% below median |
| Fa Fu F Ferrous Fumerate … | Ferrous sulfate + Folic acid | 150 mg + 0.5 mg | Tablet | 3 × 10's | 037776 | PKR 46.16 | PKR 1.54/tablet | 7% below median |
| Fa Fu F Ferrous Fumerate … | Ferrous sulfate + Folic acid | 150 mg + 0.5 mg | Tablet | 1 × 10's | 037776 | PKR 16.62 | PKR 1.66/tablet | Near median |
| Fa-Cin | Levofloxacin | 250 mg | Tablet | 1 x 10's | 051048 | PKR 461.65 | PKR 46.17/tablet | Near median |
| Fa-Cin | Levofloxacin | 500 mg | Tablet | 1 x 10's | 051049 | PKR 768.18 | PKR 76.82/tablet | Near median |
| Facemol | Paracetamol | 500 mg | Tablet | 20 × 10's | 033569 | PKR 184.66 | PKR 0.92/tablet | 75% below median |
| Facloz | Clotrimazole | 50 mg | Tablet | 1's | 033562 | PKR 118.19 | PKR 118.19/tablet | No comparator |
| Fagopine 6 | Olanzapine + Fluoxetine | 25 mg + 6 mg | Capsule | 14's | 091346 | PKR 402.56 | PKR 28.75/capsule | 6% below median |
| Faprazole | Omeprazole | 20 mg | Capsule | 2 x 7's | 087482 | PKR 265.90 | PKR 18.99/capsule | Near median |
| Faprazole | Omeprazole | 40 mg | Capsule | 2 x 7's | 087483 | PKR 461.65 | PKR 32.98/capsule | Near median |
| Fasayin | Simvastatin | 10 mg | Tablet | 1 × 10's | 033565 | PKR 219.74 | PKR 21.97/tablet | 25% below median |
| Fendronate Na | Alendronate | 70 mg | Tablet | 1 x 10's | 048981 | PKR 2,769.88 | PKR 276.99/tablet | No comparator |
| Luart DS | Artemether + Lumefantrine | 40 mg + 240 mg | Tablet | 8's | 064372 | PKR 487.50 | PKR 60.94/tablet | Near median |
| Piproxcin | Ciprofloxacin | 250 mg | Tablet | 1 x 10's | 051043 | PKR 240.05 | PKR 24.01/tablet | 6% below median |
| Piproxcin | Ciprofloxacin | 500 mg | Tablet | 1 x 10's | 051044 | PKR 397.01 | PKR 39.70/tablet | 7% below median |
| Polment | Polysaccharide iron complex | 150 mg | Capsule | 3 x 10's | 101198 | PKR 609.38 | PKR 20.31/capsule | 15% below median |
| QuinazoleSource observed | Metronidazole (Benzoate) | — | Tablet | 6 × 10's | 035321Official source ↗ | No indexed price | — | — |
| Rafitadine | Ranitidine | 150 mg | Tablet | 1 × 10's | 037669 | PKR 103.41 | PKR 10.34/tablet | 7% below median |
| Ratnox | Itraconazole | 100 mg | Capsule | 4's | 098986 | PKR 553.97 | PKR 138.49/capsule | Near median |
| Ze Farm | Azithromycin | 250 mg | Capsule | 1 x 10's | 087481 | PKR 470.88 | PKR 47.09/capsule | Near median |
| Ze Farm | Azithromycin | 250 mg | Capsule | 1 x 6's | 087481 | PKR 282.52 | PKR 47.09/capsule | Near median |
| Zirow | Azithromycin | 250 mg | Tablet | 1 × 10's | 051036 | PKR 461.64 | PKR 46.16/tablet | Near median |
| Zirow | Azithromycin | 250 mg | Tablet | 1 x 6's | 051036 | PKR 276.99 | PKR 46.17/tablet | Near median |
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.